Standard Versus Extended Pancreaticoduodenectomy in Treating Adenocarcinoma of the Head of the Pancreas

doi:10.1016/S1001-9294(13)60031-0

摘要/Abstract

摘要：

Between January 1994 and December 2011, 165 patients with biopsy-proven adenocarcinoma of the pancreatic head were treated in West China Hospital, among whom 93 underwent SPD and 72 had EPD. Complications and survival after the surgery were analyzed retrospectively.

The median operation time of the EPD group was longer compared with the SPD group (375 minutes vs.310 minutes, P<0.01), the volume of blood transfusion was larger (700 mL vs.400 mL, P<0.05), while the median hospital stay (13.5 days vs.12 days, P= 0.79) and the total complication rates were comparable (34.7% vs.32.4%, P=0.93). The total recurrence rates of the SPD and EPD groups were not significantly different (52.7% vs. 43.1%, P=0.83). No significant differences were found between the SPD and EPD groups in 1-year (81.7% vs. 86.1%), 3-year (38.7% vs. 43.1%), 5-year (16.7% vs. 19.4%), and median survivals (19.8 months vs. 23.2 months, P= 0.52).

The postoperative complications and survival donot differ significantly between SPD and EPD.

关键词: pancreas, cancer, pancreaticoduodenectomy, standard resection, extended resection

Abstract:

The postoperative complications and survival donot differ significantly between SPD and EPD.

Key words: pancreas, cancer, pancreaticoduodenectomy, standard resection, extended resection

Jun Gong, Gang Mai, Zhen-jiang Zheng, Guang-ming Xiang, Wei-ming Hu, Bo-le Tian, Zhao-da Zhang, and Xu-bao Liu. Standard Versus Extended Pancreaticoduodenectomy in Treating Adenocarcinoma of the Head of the Pancreas[J].Chinese Medical Sciences Journal, 2013, 28(2): 107-112.

参考文献 35

1.	Jemal A, Siegel R, Ward E,et al. Cancer statistics, 2006.
	CA Cancer J Clin 2006; 56:106-30.
2.	Ferlay J, Shin HR, Bray F,et al. Estimates of worldwide burden of cancer in 2008:GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.
3.	O00092;Sullivan A, Kocher HM. Pancreatic cancer. Clin Evid (Online) 2007;2007:0409.
4.	Lillemoe KD, Grosfeld JL. Pancreatic cancer - progress made. J Am Coll Surg 2007;205:S87-9.
5.	Ueda M, Endo I, Nakashima M,et al. Prognostic factors after resection of pancreatic cancer. World J Surg 2009;33:104-10.
6.	Zacharias T, Jaeck D, Oussoultzoglou E,et al. Impact of lymph node involvement on long-term survival after R0 pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas. J Gastrointest Surg 2007;11:350-6.
7.	Bosman FT,Carneiro F,Hruban RH,et al Tumours of the pancreas. In:WHO Classification of Tumours of the Digestive Syste.Lyon:IARC Press;2010. p.219-50.
8.	Edge SB, Compton CC. The American Joint Committee on Cancer:the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010;17:1471-4.
9.	Hackert T, B000fc;chler MW, Werner J. Current state of surgical management of pancreatic cancer. Cancer 2011;3:1253-73.
10	Mancuso A, Calabr000f2; F, Sternberg CN. Current therapies and advances in the treatment of pancreatic cancer. Crit Rev Oncol Hematol 2006;58:213-41.
11	Linder S, Bostr000f6;m L, Nilsson B. Pancreatic cancer in Sweden 1980-2000:a population-based study of hospitalized patients concerning time trends in curative surgery and other interventional therapies. J Gastrointest Surg 2006;10:672-8.
12	Kuhlmann KF, de Castro SM, Wesseling JG,et al. Surgical treatment of pancreatic adenocarcinoma:actual survival and prognostic factors in 343 patients. Eur J Cancer 2004;40:549-58.
13	Ruiz-Tovar J, Mart000ed;n-P000e9;rez E, Fern000e1;ndez-Contreras ME,et al. Identification of prognostic factorsin pancreatic cancer. Cir Cir 2011;79:313-22.
14	Yeo CJ, Cameron JL, Sohn TA. et al, Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s:pathology, complications, and outcomes. Ann Surg 1997;226:248-57.
15	Simunovic M, To T, Theriault M,et alRelation between hospital surgical volume and outcome for pancreatic resection for neoplasm in a publicly funded health care system,. CMAJ 1999; 160:643-8.
16	Reddy SK, Tyler DS, Pappas TN,et al. Extended resection for pancreatic adenocarcinoma. Oncologist 2007;12:654-63.
17	O00092;Morchoe CC. Lymphatic system of the pancreas. Microsc Res Tech 1997;37:456-77.
18	Sakai M, Nakao A, Kaneko T,et al. Para-aortic lymph node metastasis in carcinoma of the head of the pancreas. Surgery 2005;137:606-11.
19	Freelove R, Walling AD. Pancreatic cancer:diagnosis and management. Am Fam Physician 2006;73:485-92.
20	Salin TT, Fujii T, Kanda M,et al. Prognostic implications of lymph node metastases in carcinoma of the body and tail of the pancreas. Pancreas 2011;40:1029-33.
21	Yamamoto J, Saiura A, Koga R,et al. Improved survival of left-sided pancreas cancer after surgery. Jpn J Clin Oncol 2010;40:530-6.
22	Amikura K, Kobari M, Matsuno S. The time of occurrence of liver metastasis in carcinoma of the pancreas. Int J Pancreatol 1995;17:139-46.
23	Verbeke CS, Leitch D, Menon KV,et al. Redefining the R1 resection in pancreatic cancer. Br J Surg 2006;93:1232-7.
24	Cecil TD, Sexton R, Moran BJ,et al. Total mesorectal excision results in low local recurrence rates in lymph node-positive rectal cancer. Dis Colon Rectum 2004;47:1145-9.
25	B000fc;chler P, Friess H, M000fc;ller M,et al. Survival benefit of extended resection in pancreatic cancer. Am J Surg 2007;194:S120-6.
26	Capussotti L, Massucco P, Ribero D,et al. Extended lymphadenectomy and vein resection for pancreatic head cancer:outcomes and implications for therapy. Arch Surg 2003;138:1316-22.
27	Yeo CJ, Cameron JL, Lillemoe KD,et al. Pancreaticoduo- denectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adeno- carcinoma, part 2:randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 2002;236:355-66.
28	Michalski CW, Kleeff J, Wente MN,et al. Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pan- creatic cancer. Br J Surg 2007;94:265-73.
29	Iacono C, Accordini S, Bortolasi L,et al. Results of pancreaticoduodenectomy for pancreatic cancer:exten- ded versus standard procedure. World J Surg 2002;26:1309-14.
30	Yang YM, Wan YL, Tian XD,et al. Outcome of pancreatico- duodenectomy with extended retroperitoneal lympha- denectomy for adenocarcinoma of the head of the pancreas. Chin Med J (Engl) 2005;118:1863-9.
31	Popiela T, Kedra B, Sierzega M. Does extended lympha- denectomy improve survival of pancreatic cancer patients? Acta Chir Belg 2002;102:78-82.
32	Lin CC, Chen CL, Cheng YF. Modified extended distal pancreatectomy for carcinoma of body and tail of pancreas. Hepatogastroenterology 2005;52:1090-1.
33	Farnell MB, Pearson RK, Sarr MG,et al. A prospective randomized trial comparing standard pancreatoduodenec- tomy with pancreatoduodenectomy with extended lymph- adenectomy in resectable pancreatic head adenocarcinoma. Surgery 2005;138:618-28.
34	Riediger H, Keck T, Wellner U,et al. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg 2009;13:1337-44.
35	Pedrazzoli S, DiCarlo V, Dionigi R,et al. Standard versus extended lymphadenectomy associated with pancrea- ticoduodenectomy in the surgical treatment of adeno- carcinoma of the head of the pancreas:a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 1998;228:508-17.

[1]	Shu-bo Tian, Jian-chun Yu*, Wei-ming Kang, Zhi-qiang Ma, Xin Ye, Chao Yan, Ya-kai Huang. Effect of Neoadjuvant Chemotherapy Treatment on Prognosis of Patients with Advanced Gastric Cancer: a Retrospective Study[J]. Chinese Medical Sciences Journal, 2015, 30(2): 84-89.
[2]	Jin Wen, Han-zhong Li, Zhi-gang Ji, Jing Jin. Effects of Sunitinib Malate on Growth of Human Bladder Transitional Cell Line T24 In Vitro^△[J]. Chinese Medical Sciences Journal, 2015, 30(1): 51-55.
[3]	Chao-xian Zhang, Yong-mei Qin, Li-ke Guo. Correlations Between Polymorphisms of Extracellular Superoxide Dismutase, Aldehyde Dehydrogenase-2 Genes, as Well as Drinking Behavior and Pancreatic Cancer[J]. Chinese Medical Sciences Journal, 2014, 29(3): 162-166.
[4]	Yi Bao*,Ling-juan Ruan, Juan-fen Mo. Low Trichorhinophalangeal Syndrome 1 Gene Transcript Levels in Basal-like Breast Cancer Associate with Mesenchymal-to-epithelial Transition[J]. Chinese Medical Sciences Journal, 2013, 28(3): 129-134.
[5]	Yan-yan Chen, Liu-bo Wang, Hui-li Zhu, Xiang-yang Li, Yan-ping Zhu, Yu-lei Yin, Fan-zhen Lü, Zi-li Wang, Jie-ming Qu. Relationship Between Programmed Death-ligand 1 and Clinicopathological Characteristics in Non-small Cell Lung Cancer Patients[J]. Chinese Medical Sciences Journal, 2013, 28(3): 147-151.
[6]	Ke Dong, Wei Xiong, Xiao-jiong Yu*, and Chun Gu. Clinical Study on Suspension Pancreatic-Duct-Jejunum End-to-Side Continuous Suture Anastomosis in Pancreaticoduodenectomy[J]. Chinese Medical Sciences Journal, 2013, 28(1): 34-38.
[7]	Guo-gui Sun, Wan-ning Hu, Jun Zhang, Cheng-lin Li, and Cong-rong Yang. Effect of Nitric Oxide on Esophageal Cancer Cell Line TE-1[J]. Chinese Medical Sciences Journal, 2013, 28(1): 44-49.
[8]	Yan Lv?*, Yun Niu, Xiu-min Ding, Xu-qi Xiao. Oncogenic Role of Skp2 and p27Kip1 in Intraductal Proliferative Lesions of the Breast△[J]. Chinese Medical Sciences Journal, 2012, 27(3): 161-166.
[9]	Bo Jin*, Yan-ping Liu, Hai-jiang Wang, and Qi-shan Wang. Gastric Metastasis of Atypical Medullary Carcinoma from Breast: a Case Report[J]. Chinese Medical Sciences Journal, 2012, 27(2): 121-124.
[10]	Yan Cai, Chun-jie Hu, Jia Wang, Ze-hua Wang. Influence of Deleted in Colorectal Carcinoma Gene on Proliferation of Ovarian Cancer Cell Line SKOV-3 In Vivo and In Vitro[J]. Chinese Medical Sciences Journal, 2011, 26(3): 175-181.
[11]	Peng Jin, Jian-qiu Sheng*, Ying-hui Zhang, Ai-qin Li, Zi-tao Wu and Shi-rong Li. Expression of cyclooxygenase-2 and its relationship with mismatch repair and microsatellite instability in hereditary nonpolyposis colorectal cancer[J]. Chinese Medical Sciences Journal, 2010, 25(4): 206-210.
[12]	Peng Jin, Xiao-ming Meng, Jian-qiu Sheng*, Zi-tao Wu, Lei Fu, He-juan An, Ying Han and Shi-rong Li. Clinicopathological features of non-familial colorectal cancer with high-frequency microsatellite instability[J]. Chinese Medical Sciences Journal, 2010, 25(4): 228-232.
[13]	Ke Lü, Qing Dai, Zhong-hui Xu, Yi-xiu Zhang, Li Tan, Yan Yuan and Yu-xin Jiang. Ultrasonographic Characteristics of Intraductal Papillary Mucinous Neoplasm of the Pancreas[J]. Chinese Medical Sciences Journal, 2010, 25(3): 151-155.
[14]	Li Peng, Qiang Sun, Zhi-yong Liang, Yi-dong Zhou, Feng Mao and Jing-hong Guan. Pure Mucinous Carcinoma of the Breast: a Clinicopathologic Analysis with 56 Patients[J]. Chinese Medical Sciences Journal, 2010, 25(2): 115-118.
[15]	Liu-luan Zhu, Ying Cui, Yong-sheng Chang and Fu-de Fang. A Second Protein Marker of Caveolae: Caveolin-2[J]. Chinese Medical Sciences Journal, 2010, 25(2): 119-124.

优先出版

当期目次

过刊浏览

虚拟专题

作者中心

评阅者中心